Wednesday, December 11, 2019

QualityStocksNewsBreaks – Hemptown USA Unveils New CBG-Based Product Line at MJBizCon 2019; Reports 2019 Harvest Results


Hemptown USA, a privately-owned grower of full-spectrum, feminized hemp using premium-seed genetics, on Tuesday announced that the company revealed a portion of its new line of cannabigerol (“CBG”) products at the 2019 MJBizCon in Las Vegas, Nevada. Hemptown USA will be at booth C3831 at the 2019 MJBizCon Conference taking place Dec. 11-13, 2019. The new suite of products includes the Hemptown CBG Tincture, the Hemptown Salve Balm, and an assortment of capsules intended for various uses. The company is also promoting its new Hemptown Chew gum, which contains the highest levels of hemp-derived CBD and CBG cannabinoids currently accessible on the market. In addition, the company also reported a successful 2019 harvest. Among other highlights, the company reportedly achieved its objectives for the year; expanded the 50-acre cultivation operation in Oregon in 2018 to roughly 500 acres; and had a total of more than 1,500 acres in three states where planting, harvesting and drying of over 2 million pounds of CBG and CBD industrial hemp were successfully completed. “Our new line of CBG-infused products further advances Hemptown’s leadership position in the hemp industry. Hemptown is cultivating and harvesting over 500 acres of genetics that produce plants rich in CBG, which represents about 40% of the entire 2019 U.S. CBG crop, in our estimation. This is just the beginning, and we look forward to being the gold standard in CBG-based products and rolling out even more products in 2020 as part of our Kirkman acquisition,” Hemptown USA president and co-founder Michael Townsend stated in the news release. “Additionally, we third-party test each batch of our products and post results on the Hemptown website so consumers can be assured that the products they purchase deliver exactly what is claimed.”

To view the full press release, visit http://ibn.fm/X7gW2

About Hemptown USA

Hemptown USA is growing some of the finest cannabinoid-rich hemp plants in the world to meet the ever-increasing global demand for premium cannabinoid products. In total, the company cultivated more than 1,500 acres in three states – Oregon, Colorado and Kentucky. Expanded farmland spanning three states, together with extraction and processing capabilities, are the foundation for Hemptown USA’s vertically integrated model as the company pushes into the consumer packaged goods sectors with top-quality branded product lines. Due in large part to the recent acquisition of Kirkman Group, an FDA-licensed and cGMP (Current Good Manufacturing Practice) certified operating nutraceutical business based in Oregon, Hemptown USA is well-positioned to capitalize on a global market expected to exceed $22 billion by 2020. For more information, visit the company’s website at www.HemptownUSA.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php


No comments: